findmyKOL

Muthoka Mutinga, MD

Basic profile

Brigham and Women's Hospital

ORCIDNone on fileNPI
RegionBoston, MA · NortheastSpecialtyGastroenterologyFocusGastroenterology
Last active 2018findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2018Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Muthoka Mutinga is a Gastroenterology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 23 publications with 742 citations (h-index 10).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
23publications

Distinct works indexed by OpenAlex.

742citations

Total citations across indexed works.

10h-index

Hirsch index, productivity × impact (OpenAlex).

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1153 Centre St
Suite 45
Boston, MA 021303446

Telephone

617-522-9996

Registry record last updated 15 Dec 2011.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    93%
    Osmotic Laxative27.1%
    Gavilyte-G53%Gavilyte-C35%Lactulose7%Peg-3350 And Electrolytes6%
    Part D<11 patients
    Proton pump inhibitor23.6%
    Omeprazole56%Pantoprazole Sodium27%Esomeprazole Magnesium6%Rabeprazole Sodium5%Lansoprazole5%
    Part D<11 patients

    + 10 more classes in this area

  • Cardiovascular

    5.7%
    Bile Acid Sequestrant4.3%
    Colestipol Hcl70%Cholestyramine30%
    Part D<11 patients
    Aldosterone antagonist (MRA)1.3%
    Spironolactone100%
    Part D<11 patients
  • Anti-infectives

    1.3%
    Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor1.3%
    Entecavir100%
    Part D<11 patients
Where care is delivered (Part B)67.4% facility · 32.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”